Chimerix names two new executives Chimerix names two new executives Peter Payne becomes SVP, Business Development and Corporate Strategy, and Roberto Guzman becomes VP, Corporate Compliance Vetter makes changes in its Development Service Division Vetter makes changes in its Development Service Division Susanne Resatz becomes President of Process Development and Manufacturing at Chicago facility Abivax makes two appointments to executive management team Abivax makes two appointments to executive management team Karl Birthistle joins as VP of Global Regulatory Affairs, while Daniel Kenny becomes VP of Business Development John Goetz steps up to position of Chief Operating Officer at Bio-Rad John Goetz steps up to position of Chief Operating Officer at Bio-Rad John Hertia and Shannon Hall are also promoted Orphanage in Mumbai gets funding for higher education from Amdipharm Mercury Orphanage in Mumbai gets funding for higher education from Amdipharm Mercury Fifteen students are given the opportunity to study for a degree by pharma company Seeking the world’s best science images Seeking the world’s best science images RPS calls for entries to the International Images for Science exhibition Dover realigns pump businesses into three focused companies Dover realigns pump businesses into three focused companies Names new leaders of each company Catalent makes another promotion Catalent makes another promotion Mark Bisset moves up to President, Catalent Asia Pacific Allied-Bristol Life Sciences appoints Satish Jindal Allied-Bristol Life Sciences appoints Satish Jindal Former Bristol-Meyers Squibb President to lead discovery of drug candidates from leading academic institutions New Chief Medical Officer for Cardio3 Biosciences New Chief Medical Officer for Cardio3 Biosciences Warren Sherman has more than three decades of experience in the cardiovascular and cell therapy fields Rapid Micro Biosystems announces new Chief Executive Rapid Micro Biosystems announces new Chief Executive Life sciences veteran joins the US company Novartis to make changes to Executive Committee after conclusion of deals with GSK and Eli Lilly Novartis to make changes to Executive Committee after conclusion of deals with GSK and Eli Lilly Three heads of Novartis divisions to leave Executive Committee Aesica appoints VP, Business Development and Business Development Director for Finished Dose Aesica appoints VP, Business Development and Business Development Director for Finished Dose To drive service in Europe and achieve further growth Steven Fasman joins Catalent as SVP and General Counsel Steven Fasman joins Catalent as SVP and General Counsel With extensive legal experience across a broad range of industries Mark Griffiths joins board of Dishman Pharmaceuticals and Chemicals Mark Griffiths joins board of Dishman Pharmaceuticals and Chemicals He has been Chief Executive of Dishman and Carbogen Amcis for three years Aptuit appoints Operations and General Manager in Verona, Italy Aptuit appoints Operations and General Manager in Verona, Italy Manuela Leone will oversee Aptuit’s drug discovery and development operations